Synterex was founded on the building blocks of diversity and inclusion; our name is derived from the Greek philosophical term for the ability of the mind to distinguish ethical versus non-ethical principles. -Jeanette Towles
DEDHAM, Mass. (PRWEB) June 18, 2020
Synterex, Inc., a business specializing in medical writing and other clinical resourcing, is proud to announce national certification as a Women’s Business Enterprise by the Center for Women & Enterprise, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC).
“Synterex was founded on the building blocks of diversity and inclusion; our name is derived from the Greek philosophical term for the ability of the mind to distinguish ethical versus non-ethical principles,” said Synterex President and founder, Jeanette Towles. “It is more important now than ever to advocate for innovation of these concepts alongside our like-minded colleagues in the biotech and pharmaceutical industry. The WBENC certification will optimize Synterex’s ability to do just that.”
WBENC’s national standard of certification implemented by the Center for Women & Enterprise is a meticulous process including an in-depth review of the business and site inspection. The certification process is designed to confirm the business is at least 51% owned, operated and controlled by a woman or women.
By including women-owned businesses among their suppliers, corporations and government agencies demonstrate their commitment to fostering diversity and the continued development of their supplier diversity programs.
To learn more about Synterex, Inc., please visit https://www.synterex.com.
About Synterex, Inc.:
Synterex provides clinical solutions, including publishing, clinical science and operations, project management, medical and regulatory writing services, and IT collaboration services, for the biotech and pharmaceutical industry. Synterex staffers are seasoned and dedicated, with extensive experience doing the work hands-on as well as building and leading teams. We are committed to applying our current regulatory knowledge across a broad spectrum of therapeutic areas—including oncology, rare disease, and infectious disease—to help clients deliver important new therapies to patients expediently.
Founded in 1997, WBENC is the nation’s leader in women’s business development and the leading third-party certifier of businesses owned and operated by women, with more than 13,000 certified Women’s Business Enterprises, 14 national Regional Partner Organizations, and over 300 Corporate Members. More than 1,000 corporations representing America’s most prestigious brands as well as many states, cities, and other entities accept WBENC Certification. For more information, visit http://www.wbenc.org.